A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
President Donald Trump didn't wait long in his second term to begin shaking things up in Washington, D.C. In less than two ...
The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.
Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
The Inflation Reduction Act (IRA) of 2022 brought substantial modifications to the Medicare program, which are still reflected in 2025. One of these changes was a new limit for ded ...
South Dakota’s House of Representatives voted to advance House Joint Resolution 5001, an amendment to the state constitution ...
The new Department of Government Efficiency can't go after Medicare or Social Security. That leaves Medicaid in a vulnerable ...
Arizona officials acknowledged that a fraud scheme targeting Indigenous people with addictions cost taxpayers $2.5 billion.
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
After several years of huge financial losses, hospitals across Washington are doing better financially, in large part due to ...
Given the prevalence of managed care, it’s incumbent upon the industry to ensure that there is a robust supplier pool.
The Medicaid Fraud and Residential Abuse Unit receives 75 percent of its funding from the U.S. Department of Health and Human Services under a grant award totaling $1,332,724 for Federal fiscal year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback